These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 25287588)
1. Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels. Hoffmann CJ; Gallant JE Infect Dis Clin North Am; 2014 Dec; 28(4):549-61. PubMed ID: 25287588 [TBL] [Abstract][Full Text] [Related]
2. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
3. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)]. Panel de expertos de GESIDA y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714 [TBL] [Abstract][Full Text] [Related]
4. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764 [TBL] [Abstract][Full Text] [Related]
5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
6. "In reality, it is complex and difficult": UK nurses' perspectives on "treatment as prevention" within HIV care. Evans C; Bennett J; Croston M; Brito-Ault N; Bruton J AIDS Care; 2015; 27(6):753-7. PubMed ID: 25650545 [TBL] [Abstract][Full Text] [Related]
7. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India. Gupta SB; Pujari SN; Joshi SR; Patel AK; J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742 [TBL] [Abstract][Full Text] [Related]
8. Using HIV viral load to guide treatment-for-prevention interventions. Novitsky V; Essex M Curr Opin HIV AIDS; 2012 Mar; 7(2):117-24. PubMed ID: 22258501 [TBL] [Abstract][Full Text] [Related]
9. Undetectable viral load and HIV transmission dynamics on an individual and population level: where next in the global HIV response? Bavinton BR; Rodger AJ Curr Opin Infect Dis; 2020 Feb; 33(1):20-27. PubMed ID: 31743122 [TBL] [Abstract][Full Text] [Related]
10. Treatment as prevention in resource-limited settings: is it feasible to maintain HIV viral load suppression over time? Socías ME; Rotryng F; Lapadula P; Medrano M; Paz D; Stern L; Lambierto A; Pryluka D J Infect Dev Ctries; 2013 Aug; 7(8):593-9. PubMed ID: 23949294 [TBL] [Abstract][Full Text] [Related]
11. Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa. Mutevedzi PC; Newell ML Trop Med Int Health; 2014 Sep; 19(9):1015-28. PubMed ID: 24976370 [TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals for HIV prevention: when should they be recommended? Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection. Kalapila AG; Marrazzo J Med Clin North Am; 2016 Jul; 100(4):927-50. PubMed ID: 27235622 [TBL] [Abstract][Full Text] [Related]
14. Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda. Dieffenbach CW Curr Opin HIV AIDS; 2012 Mar; 7(2):106-10. PubMed ID: 22227584 [TBL] [Abstract][Full Text] [Related]
15. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy. Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798 [TBL] [Abstract][Full Text] [Related]
16. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City. Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545 [TBL] [Abstract][Full Text] [Related]
17. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052. Forsyth AD; Valdiserri RO Curr Opin HIV AIDS; 2012 Mar; 7(2):111-6. PubMed ID: 22227586 [TBL] [Abstract][Full Text] [Related]
18. Minimal interference: A basis for selecting ART for prevention with positives. Lebouché B; Engler K; Lévy JJ; Gilmore N; Spire B; Rozenbaum W; Routy JP AIDS Care; 2013; 25(10):1284-90. PubMed ID: 23394079 [TBL] [Abstract][Full Text] [Related]
19. Patching a leaky pipe: the cascade of HIV care. Kilmarx PH; Mutasa-Apollo T Curr Opin HIV AIDS; 2013 Jan; 8(1):59-64. PubMed ID: 23211779 [TBL] [Abstract][Full Text] [Related]